Ultime notizie per Cuentas (OTC:CUEN) Azioni

Cuentas

Cuentas Inc is a FinTech e-banking and e-commerce service provider with proprietary technology aimed at providing solutions for the underbanked and un-banked Hispanic and Latino population. It operates in three segments: Telecommunications, wholesale telecommunication services and digital products and general purpose reloadable cards. Its services include mobile banking, online banking, prepaid debit, ACH and mobile deposits, cash remittance, peer-to-peer money transferring, and providing access to bank accounts for customers who previously could not obtain bank accounts. The proprietary Cuentas General Purpose Reloadable (GPR) Card provides holders with a digital wallet, discounts for purchases at major physical and online retailers, rewards, and the ability to purchase digital content.

Cuentas Inc

<p>Bragg reiterates its 2024 full year revenue guidance range of EUR 102.0-109.0 million (USD 114.2-122.1 million) and its full year Adjusted EBITDA range of EUR 15.2-18.5 million (USD 17.0-20.7 million), noting that the Company is currently tracking to the lower end of guidance.</p>
<p>Bragg is actively advancing a robust pipeline of opportunities that is anticipated to drive strong momentum as we enter 2025. The outlook for 2025 remains positive, with expectations of sustained double-digit top line growth, expanding bottom line margins, and increased operational leverage, further strengthening Bragg's position in the market. The preceding guidance and outlook constitute forward-looking information within the meaning of applicable securities laws, and is based on a number of assumptions and subject to a number of risks.</p>


News

Guidance

BRAG

Bragg Gaming Reiterated FY24 Revenue Guidance Of $114.2M - $122.1M, Est $101.52M

<p>Chemomab Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMMB#NASDAQ">CMMB</a>) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.01) by 1900 percent.</p>


Earnings

Earnings Misses

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

Chemomab Therapeutics Q3 2024 GAAP EPS $(0.20) Misses $(0.01) Estimate

Biotech

Health Care

General

IVVD

Invivyd Announces That The New England Journal Of Medicine Has Published A Peer-reviewed Letter To The Editor Describing The Pemgarda (Pemivibart) Immunobridging Emergency Use Authorization Pathway, As Well As An Updated Correlate Of Protection Curve For Prevention Of Symptomatic Covid-19 Via Recombinant Monoclonal Antibodies Such As Pemivibart

<p>Innventure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INV#NASDAQ">INV</a>) reported quarterly losses of $(0.94) per share. This is a 11.9 percent decrease over losses of $(0.84) per share from the same period last year.  The company reported $317.00 thousand in sales this quarter. This is a 15.69 percent increase over sales of $274.00 thousand the same period last year.</p>


Innventure Q3 EPS $(0.94) Down From $(0.84) YoY, Sales $317.00K Up From $274.00K YoY

ONEW

OneWater Marine Expects FY25 Revenue Of $1.7B - $1.85B, Adjusted EPS Of $1.00 - $2.00

<p>Gambling.com Group today updated its 2024 full-year revenue and Adjusted EBITDA guidance. The Company now expects full year revenue of $125 million to $127 million and Adjusted EBITDA of $46.5 million to $48.5 million. The midpoints of the new full year revenue and Adjusted EBITDA guidance ranges represent year-over-year growth of 16% and 29%, respectively. The Company's updated outlook compares to the guidance provided on August 15, 2024 for revenue of $123 million to $127 million and Adjusted EBITDA of $44 million to $47 million.</p>
<p>The Company's guidance assumes:</p>
<ul>
<li>No additional North American markets come online over the balance of 2024</li>
<li>Apart from the completed acquisition of Freebets.com and related assets, no benefit from any additional acquisitions in 2024</li>
<li>Full year cost of sales of approximately $7.5 million, of which $5.4 million was incurred in the first nine months of 2024</li>
<li>An average EUR/USD exchange rate of 1.065 for the fourth quarter of 2024</li>
</ul>


GAMB

Gambling.com Group 2024 Outlook: The Company Now Expects Revenue Of $125M-$127M (Prior $123M-$127M) Vs. $124.765M Consensus And Adjusted EBITDA Of $46.5M-$48.5M (Prior $44M-$47M)

Earnings Beats

Bragg Gaming Group Q3 2024 GAAP EPS €(0.01) Beats €(0.05) Estimate, Sales €26.169M Beat €25.484M Estimate

<p>Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) reported quarterly losses of $(0.00) per share. This is a 102.5 percent decrease over earnings of $0.04 per share from the same period last year. The company reported $5.25 million in sales this quarter. This is a 20.42 percent decrease over sales of $6.60 million the same period last year.</p>


MITQ

Moving iMage Technologies Q1 EPS $(0.00) Down From $0.04 YoY, Sales $5.25M Down From $6.60M YoY

<p>HSBC  analyst Frank Lee   maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and raises the price target from $145 to $200.</p>


Price Target

Analyst Ratings

NVDA

HSBC Maintains Buy on NVIDIA, Raises Price Target to $200

Buybacks

Hilton Authorizes Repurchase Of Additional $3.5B Of Common Stock, Bringing Total Amount Authorized To ~$4.8B

<p>Rodman &amp; Renshaw  analyst Brandon Folkes   initiates coverage on Rockwell Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMTI#NASDAQ">RMTI</a>) with a Buy rating and announces Price Target of $5.</p>


Initiation

RMTI

Rodman & Renshaw Initiates Coverage On Rockwell Medical with Buy Rating, Announces Price Target of $5

<p>Using analysis from an open-label, long-term treatment study of the RNS&#xAE; System, Rapport will present key new data on the correlation between the reduction in long episode (LE) frequency (abnormal electrographic activity) and clinically meaningful reduction ( 50%) in patient reported seizures. The LE biomarker is being used in the Company's novel Phase 2a proof-of-concept trial of lead product candidate RAP-219 as a potential anti-seizure treatment for patients with drug-resistant focal epilepsy. The Phase 2a trial measures LE frequency reduction in patients who have an implanted responsive neurotransmitter device (RNS&#xAE; System) in response to RAP-219 treatment, demonstrating expected reduced clinical seizure frequency.</p>


RAPP

Rapport Therapeutics Announced Multiple Presentations At The Upcoming American Epilepsy Society Annual Meeting

<p>Talen Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLN#NASDAQ">TLN</a>) reported quarterly earnings of $3.16 per share which beat the analyst consensus estimate of $1.78 by 77.53 percent.  The company reported quarterly sales of $650.000 million which beat the analyst consensus estimate of $564.837 million by 15.08 percent.  This is a 25.97 percent increase over sales of $516.000 million the same period last year.</p>


Talen Energy Q3 2024 GAAP EPS $3.16 Beats $1.78 Estimate, Sales $650.000M Beat $564.837M Estimate

BLUE

bluebird bio Sees Q4 2024 Revenue At Least $25M Vs $27.85M Estimate

SACH

Sachem Cap Q3 2024 GAAP EPS $(0.13) Misses $0.03 Estimate, Sales $14.785M Miss $14.802M Estimate

<p>OneWater Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEW#NASDAQ">ONEW</a>) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $0.17 by 311.76 percent. This is a 185.71 percent decrease over earnings of $0.42 per share from the same period last year.  The company reported quarterly sales of $377.86 million which missed the analyst consensus estimate of $421.09 million by 10.27 percent.  This is a 16.21 percent decrease over sales of $450.98 million the same period last year.</p>


OneWater Marine Q4 2024 Adj EPS $(0.36) Misses $0.17 Estimate, Sales $377.86M Miss $421.09M Estimate

<p>Rodman &amp; Renshaw  analyst Brandon Folkes   initiates coverage on Achieve Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHV#NASDAQ">ACHV</a>) with a Buy rating and announces Price Target of $12.</p>


ACHV

Rodman & Renshaw Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $12

<p>Iterum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRM#NASDAQ">ITRM</a>) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.20) by 20 percent. This is a 80 percent increase over losses of $(1.20) per share from the same period last year.</p>


ITRM

Iterum Therapeutics Q3 2024 Adj. EPS $(0.24) Misses $(0.20) Estimate. Cash And Equivalents Of $14.5M

OCUL

Ocular Therapeutix's Cash Balance Of $427.2M As Of September 30, 2024, Expected To Fund Operations Into 2028

<p>Gambling.com Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAMB#NASDAQ">GAMB</a>) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.18 by 38.89 percent.  The company reported quarterly sales of $32.118 million which beat the analyst consensus estimate of $30.397 million by 5.66 percent.  This is a 36.92 percent increase over sales of $23.458 million the same period last year.</p>


Gambling.com Gr Q3 2024 Adj. EPS $0.25 Beats $0.18 Estimate, Sales $32.118M Beat $30.397M Estimate

Cuentas Inc (CUEN) is down -4.52%% today. CUEN has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on CUEN!See Full CUEN ReportCUEN stock closed at $2.21 and is down -$0.10 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most inve

Should You Sell Cuentas Inc (CUEN) Stock Tuesday Morning?

CVAC, REE and NEON among mid-day movers

The market has been down on Cuentas Inc (CUEN)  stock recently. CUEN gets a Bearish score from InvestorsObserver Stock Sentiment Indicator. Cuentas Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CUEN!See Full CUEN ReportWhat is Stock Sentiment?When making investmen

Should You Buy Cuentas Inc (CUEN) Stock on Wednesday?

These Technology stocks are trading higher:-Ebang International Holdings Inc (EBON) stock is trading at $13.74, a gain of $5.31, or 63.67%, on high volume.  Ebang International Holdings Cl gets a Sentiment Score of Very Bullish from InvestorsObserver.  -Mawson Infrastructure Group Inc (MIGI) stock is trading at $2.05, a ga

Technology Stocks on the Move Wednesday: EBON, MIGI, ANY, CAN, CUEN, MINM, DXC, MVIS

Cuentas sells Brooksville in Florida property for $7.2 million

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Cuentas</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/cuen-stock-quote/"><strong>CUEN</strong></a></span>) just reported results for the fourth quarter of 2023.</p><ul><li>Cuentas reported earnings per share of $1.14.</li><li>The company reported revenue of $1.35 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/04/cuen-stock-earnings-cuentas-for-q4-of-2023/">CUEN Stock Earnings: Cuentas Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

CUEN Stock Earnings: Cuentas Reported Results for Q4 2023

Cuentas reports FY results

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Cuentas</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/cuen-stock-quote/"><strong>CUEN</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>Cuentas reported earnings per share of -15 cents.</li><li>The company reported revenue of $639,000.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/cuen-stock-earnings-cuentas-for-q1-of-2024/">CUEN Stock Earnings: Cuentas Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

CUEN Stock Earnings: Cuentas Reported Results for Q1 2024

An update from Cuentas (CUEN) is now available. Cuentas, Inc. faces a setback as the interested buyer for their "Brooksville Property" could not fi...

Cuentas Property Sale Falls Through, Seeks New Buyers

Cuentas (CUEN) has shared an announcement. Cuentas Inc. has finalized a Termination Agreement with Interactive Communications International, Inc. (...

Cuentas Finalizes Termination Agreement, Maintains Key Partnerships

ATAK

BMRA

CONN

CUEN

CVAC

EBON

GHRS

ICCT

MDVL

MIGI

MINM

MOTS

MVIS

NEON

PBLA

PLSE

RVYL

SFWL

SING

SMAP

ZJYL

Press Releases

CUEN – Cuentas, Inc. Reaffirms Its Dominance in Telecommunications, Financial Technology and Real Estate and Garners Unwavering Shareholder Backing at the Recent Annual General Meeting

CUEN – Cuentas, Inc. CEO Unveils Triumph in 2023: Unprecedented Shareholder Support in Proxy Vote and Shares Visionary Fiscal Year 2024 Plans

CUEN – Cuentas, Inc. Announces Financing Terms for  Tampa Real Estate Venture Through Lender $3,0000,000 Mortgage Extension

CUEN – Cuentas, Inc. Unveils Fintech Offering Advancements, Spotlighting Rapid Expansion in Core Services and Products Tailored to Captivate the Thriving Hispanic Diaspora Market

CUEN – Unlocking Value: Cuentas, Inc. Sells Brooksville Real Estate for $7.2 Million, Unleashing Double Digit Profits and Rewards Founders Strategic Vision

CUEN – Cuentas Releases Annual Financial Reports Reflecting Improved Business Transition Results, Revenues and Profitability

CUEN – Cuentas Announces Remarkable Q1 Performance with 898% Year-Over-Year Sales Surge and Strategic Transactions

CUEN – Cuentas, Inc.  And World Mobile Group, Ltd. Unveil Global Roaming And Financial Services In The United States

CUEN – Cuentas, Inc. Steps Up to Support 23 Million Households with New Programs Following Affordable Connectivity Program Termination

Cuentas, Inc. Announces New Direction from Fintech to Digital Content & Product Distribution together with Mobile Data and Cellular offerings.

CUENW

SWISF

Comments

Cuentas

Notizie

Ultime notizie per Cuentas (OTC:CUEN) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO